Maze Therapeutics, Inc. SEC filings MAZE
Maze Therapeutics, Inc. has 222 filings in SEC EDGAR's recent list, going back to Jun 21, 2024. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 144 | Notice of proposed sale | Nov 2, 2026 | — |
| 4 | Insider transaction | Oct 30, 2026 | Oct 29, 2026 |
| 144 | Notice of proposed sale | Oct 29, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 16, 2026 | Oct 15, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 4 | Insider transaction | Oct 1, 2026 | Sep 29, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 144 | Notice of proposed sale | Sep 4, 2026 | — |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| 144 | Notice of proposed sale | Sep 1, 2026 | — |
| 4 | Insider transaction | Aug 31, 2026 | Aug 28, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 13, 2026 |
| 3 | Initial insider ownership | Aug 17, 2026 | Aug 13, 2026 |
| 3 | Initial insider ownership | Aug 17, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 17, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 13, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 144 | Notice of proposed sale | Aug 3, 2026 | — |
| 4 | Insider transaction | Jul 31, 2026 | Jul 29, 2026 |
| 144 | Notice of proposed sale | Jul 29, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 144 | Notice of proposed sale | Jun 1, 2026 | — |
| 4 | Insider transaction | May 27, 2026 | May 22, 2026 |
| 8-K |
Current report
Officer or director change
|
May 22, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 144 | Notice of proposed sale | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| EFFECT | Filing | May 13, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| POS AM | Filing | May 12, 2026 | — |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 29, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Other events
|
Apr 22, 2026 | Apr 21, 2026 |
| 424B5 | Prospectus supplement | Apr 22, 2026 | — |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 1, 2026 | — |
| 4 | Insider transaction | Mar 31, 2026 | Mar 27, 2026 |
| 3 | Initial insider ownership | Mar 31, 2026 | Mar 27, 2026 |
| 144 | Notice of proposed sale | Mar 30, 2026 | — |
| 10-K | Annual report | Mar 25, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 25, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 144 | Notice of proposed sale | Mar 10, 2026 | — |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 6, 2026 | — |
| S-8 | Employee stock plan registration | Feb 4, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 4, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 29, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 144 | Notice of proposed sale | Jan 16, 2026 | — |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 8, 2026 | Jan 6, 2026 |
| 144 | Notice of proposed sale | Jan 7, 2026 | — |
| 144 | Notice of proposed sale | Jan 6, 2026 | — |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Dec 31, 2025 | Dec 29, 2025 |
| 4 | Insider transaction | Dec 31, 2025 | Dec 29, 2025 |
| 4 | Insider transaction | Dec 31, 2025 | Dec 29, 2025 |
| 144 | Notice of proposed sale | Dec 29, 2025 | — |
| 144 | Notice of proposed sale | Dec 29, 2025 | — |
| 144 | Notice of proposed sale | Dec 4, 2025 | — |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 144 | Notice of proposed sale | Nov 21, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 424B3 | Prospectus | Nov 6, 2025 | — |
| 4 | Insider transaction | Nov 5, 2025 | Nov 4, 2025 |
| 4 | Insider transaction | Oct 27, 2025 | Oct 23, 2025 |
| S-1 | Registration statement | Oct 17, 2025 | — |
| 4 | Insider transaction | Oct 7, 2025 | Oct 6, 2025 |
| 3 | Initial insider ownership | Oct 7, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 6, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 16, 2025 | Sep 15, 2025 |
| 144 | Notice of proposed sale | Sep 15, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 11, 2025 | Sep 10, 2025 |
| 4 | Insider transaction | Sep 2, 2025 | Sep 2, 2025 |
| 3 | Initial insider ownership | Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 9, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 9, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 29, 2025 | — |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 7, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 7, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 7, 2025 | — |
| SEC STAFF LETTER | Filing | Feb 6, 2025 | — |
| 4 | Insider transaction | Feb 4, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 3, 2025 |
| S-8 | Employee stock plan registration | Jan 31, 2025 | — |
| 424B4 | Prospectus | Jan 31, 2025 | — |
| EFFECT | Filing | Jan 30, 2025 | — |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| S-1MEF | Filing | Jan 30, 2025 | — |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| 3 | Initial insider ownership | Jan 30, 2025 | Jan 30, 2025 |
| CERT | Filing | Jan 30, 2025 | — |
| CORRESP | Letter to the SEC | Jan 30, 2025 | — |
| S-1/A | Amended registration statement | Jan 30, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2025 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MAZE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1842295
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.